Article view: 608

Article download: 174

Indian Journal of Clinical and Experimental Ophthalmology


Clinical indications of penetrating keratoplasty in Punjab


Full Text PDF Share on Facebook Share on Twitter


Author Details : Shakeen Singh, Pawan Prasher, Mandeep Kaur, Arushi Kakkar, Manish Chhabra

Volume : 3, Issue : 1, Year : 2017

Article Page : 91-95


Suggest article by email


Abstract

Purpose: To study the indications for penetrating keratoplasty(PKP) in Punjab.
Design: Retrospective study.
Methods: Retrospective analysis of medical records of patients who underwent PKP at Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar from January 1, 2015 to January 1, 2017 was conducted to study the indications of PKP.
Results: A total of 102 eyes of 94 patients were included in the current study, of which 75 (79.78%) were males. The mean age of the patients was 53.1 ± 17.2 (range 15 to 85) years. The most common indication for PKP was corneal opacity in 43 (42.15%) cases, followed by active infectious keratitis in 16 (15.69%), adherent leucoma in 12 (11.76%), bullous keratopathy in 10 (9.8%), failed graft in 9 (8.82%), staphyloma in 6 (5.88%), keratoconus in 1 (0.98%), and miscellaneous causes in 5 (4.9%) cases. Post infectious cause was the most common subcategory in the corneal opacity group, followed by post-trauma and post chemical burns.
Conclusions: Corneal opacity, most commonly as a result of post-infectious scarring, is the most common indication for PKP in Punjab. Patient education, preventive measures, and improvement in primary eye health care services are required to reduce the burden of corneal blindness in this region.

Keywords:
Corneal opacity, Indications, Infectious keratitis, Penetrating keratoplasty

How to cite : Singh S, Prasher P, Kaur M, Kakkar A, Chhabra M, Clinical indications of penetrating keratoplasty in Punjab. Indian J Clin Exp Ophthalmol 2017;3(1):91-95

Copyright © 2017 by author(s) and Indian J Clin Exp Ophthalmol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)